Online citations, reference lists, and bibliographies.
← Back to Search

Preparation Of Desmopressin-containing Liposomes For Intranasal Delivery.

S. Law, K. Huang, H. Y. Chou
Published 2001 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
The loading and leakage characteristics of the desmopressin-containing liposomes and the effect of liposomes on the nasal mucosa permeation and antidiuresis of desmopressin were investigated. Higher loading efficiency of desmopressin for positively charged liposomes than negatively charged liposomes was obtained, and neutral liposomes resulted in a similar loading efficiency as that of positively charged liposomes. Greater leakage of desmopressin from negatively charged liposomes than from positively charged and neutral liposomes was shown. The increase of permeability of desmopressin through the nasal mucosa indicated positively charged liposomes>negatively charged liposomes>solution. It was suggested that the enhanced contact time of positively charged liposomes with negatively charged nasal mucosa led to a high local desmopressin concentration on the penetration site to promote an effective penetration of desmopressin through the nasal mucosa. The desmopressin antidiuresis result after intranasal administration was in good agreement with the permeability result in the order of positively charged liposomes>negatively charged liposomes>solution. One of the mechanisms for the explanation of the best result on the enhancement of antidiuresis for positively charged liposomes may be the bioadhesive effect of the liposomes on the negatively charged nasal mucosa.
This paper references
10.1002/JPS.2600780610
Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin.
A. Harris (1989)
10.1002/JPS.2600751113
Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin.
A. Harris (1986)
10.1023/A:1018973029651
Prodrugs of Peptides. 18. Synthesis and Evaluation of Various Esters of Desmopressin (dDAVP)
A. H. Kahns (2004)
10.1007/BF03258235
Basic Pharmacology of Desmopressin
H. Vilhardt (1990)
10.1002/JPS.2600721108
Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors
Hong-Shian Huang (1983)
10.1023/A:1015894910416
Effects of Viscous Hyaluronate–Sodium Solutions on the Nasal Absorption of Vasopressin and An Analogue
K. Morimoto (2004)
10.1248/CPB.40.1569
Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits.
Y. Maitani (1992)
10.1016/0003-2697(80)90269-9
Colorimetric determination of phospholipids with ammonium ferrothiocyanate.
J. C. Stewart (1980)
10.1021/BI00434A042
The nature of the hydrophobic binding of small peptides at the bilayer interface: implications for the insertion of transbilayer helices.
R. Jacobs (1989)
10.1016/0378-5173(89)90129-4
Interactions of small polypeptides with dimyristoylphosphatidylcholine monolayers: effect of size and hydrophobicity
N. Williams (1989)
10.1016/0306-3623(86)90198-9
Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans.
H. Vilhardt (1986)
10.1111/j.1365-2265.1993.tb00990.x
Pharmacokinetics of 1‐deamino‐8‐d‐arginine vasopressin after various routes of administration in healthy volunteers
A. Fjellestad-Paulsen (1993)
10.1016/S0006-3495(97)78713-7
Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids.
A. S. Ladokhin (1997)
10.1111/j.2042-7158.1994.tb03876.x
Nasal Absorption of Desmopressin in Rats and Sheep. Effect of a Bioadhesive Microsphere Delivery System
H. Critchley (1994)
10.1080/02652040010000334
Characterization of calcitonin-containing liposome formulations for intranasal delivery.
S. Law (2001)
10.1002/JPS.2600770510
Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin.
A. Harris (1988)
10.1016/0378-5173(83)90027-3
Preparation and characterization of doxorubicin-containing liposomes. II. Loading capacity, long-term stability and doxorubicin-bilayer interaction mechanism
D. Crommelin (1983)
10.1081/DDC-100102275
The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits.
K. Muramatsu (1999)
Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.
V. Lee (1991)
10.1016/0378-5173(94)90206-2
Release characteristics of mitoxantrone-containing liposomes
S. Law (1994)
10.1111/J.1600-0773.1989.TB01134.X
Degradation of [mercaptopropionic acid1, D-arginine8]-vasopressin (dDAVP) in pancreatic juice and intestinal mucosa homogenate.
S. Lundin (1989)
10.1007/BF00558266
Pharmacokinetics and haematological effects of desmopressin
M. Koehler (2004)
10.1007/BF01207455
Mechanism of liposome destabilization by polycationic amino acids
R. Epand (1995)
10.1016/0378-5173(91)90226-E
Influence of bile salts on the permeability of insulin through the nasal mucosa of rabbits in comparison with dextran derivatives
N. Uchida (1991)
10.1248/BPB.16.457
Influence of liposomes on tryptic digestion of insulin.
Y. Katô (1993)
Studies of synthetic peptide analogs of the amphipathic helix. Effect of charged amino acid residue topography on lipid affinity.
P. Kanellis (1980)



This paper is referenced by
10.1016/j.lfs.2016.08.033
Development of risperidone liposomes for brain targeting through intranasal route.
Reema Narayan (2016)
10.1080/08982100802354624
Development of a Liposome Formulation for D-Cycloserine Local Delivery
T. Musumeci (2008)
10.1016/S0166-2236(00)01931-7
Neuroprotective peptide drug delivery and development: potential new therapeutics
I. Gozes (2001)
10.1016/j.ejps.2008.12.015
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate.
F. Bortolotti (2009)
10.1016/J.IJPHARM.2003.09.022
In vitro evaluation of intestinal absorption of desmopressin using drug-delivery systems based on superporous hydrogels.
A. Polnok (2004)
10.4103/0250-474X.115492
Development and Validation of a Reversed-Phase High-performance Liquid Chromatography Method for Determination of Desmopressin in Chitosan Nanoparticles
Seyed Mojtaba Taghizadeh (2013)
10.1081/LPR-100108460
ENHANCEMENT OF NASAL ABSORPTION OF CALCITONIN LOADED IN LIPOSOMES
S. Law (2001)
DEVELOPMENT AND EVALUATION OF LIPOSOMAL MUCOADHESIVE GEL FOR NASAL DELIVERY OF ACYCLOVIR
Amel Y. Hamed (2008)
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR DESMOPRESSIN FROM POLYMERIC NANOPARTICLES
Dipti Desai (2016)
Intranasal desmopressin administration
S·费恩 (2009)
10.1016/j.ijpharm.2014.07.025
Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
Yasmine M Gabal (2014)
10.3390/molecules14093754
Nasal Delivery of High Molecular Weight Drugs
Y. Ozsoy (2009)
RECENT TECHNIQUES IN NASAL DRUG DELIVERY: A REVIEW
Parmar Harshad (2010)
10.1016/J.EJPS.2008.12.015
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate
Bortolotti Fabrizio (2009)
10.1016/j.xphs.2020.04.007
Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule.
Lamis H Salem (2020)
10.1080/08982100902736571
Multilamellar liposomes of triamcinolone acetonide: preparation, stability, and characterization
B. Clares (2009)
10.1016/j.jcis.2011.01.047
Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
D. Libster (2011)
10.1002/jps.21939
Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations.
M. Migliore (2010)
10.2147/DDDT.S235004
Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation
M. M. Omar (2019)
10.2147/DDDT.S93937
Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil
Abdulrahman K Al Asmari (2016)
10.1081/LPR-120026392
Stability of Desmopressin Loaded in Liposomes
S. Law (2003)
10.1080/10717540802035251
Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation.
I. Alsarra (2008)
10.2174/2210303109666190508083142
Recent Advances and Novel Approaches for Nose to Brain Drug Delivery for Treatment of Migraine
Nidhi Sachan (2019)
To Study Effect of Process Variables on Preparation of Desmopressin Loaded Nanoparticles Using Box-Behnken Design
D. Desai (2016)
10.1080/10717540802035251
Acyclovir Liposomes for Intranasal Systemic Delivery: Development and Pharmacokinetics Evaluation
I. Alsarra (2008)
10.2165/00137696-200503030-00001
Thiomers: The Next Generation of Mucoadhesive Polymers
Andreas Bernkop-Schn rch (2005)
10.1201/B12778-8
Nasal and Pulmonary Delivery of Macromolecules to Treat Respiratory and Nonrespiratory Diseases
D. Paturi (2012)
10.1016/j.colsurfb.2018.11.025
Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: Formulation design, characterization and nasal toxicity study.
Arshiya Praveen (2019)
10.3109/9781420045260-33
Nasal Drug Delivery
P. Karla (2008)
10.1002/JPS.20069
Thiomers in noninvasive polypeptide delivery: in vitro and in vivo characterization of a polycarbophil-cysteine/glutathione gel formulation for human growth hormone.
V. Leitner (2004)
Intranasal delivery of GDNF for the treatment of Parkinson's Disease
M. Migliore (2008)
DDDT_A_235004 4413..4430
Mahmoud Mohamed Omar (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar